-
Indonesia accepts Malaysia's help to tackle wildfires
-
Denmark hails 'binding' Greenland deal with Trump
-
Indians living in Japan on stand-by to house Asian Games athletes
-
We don't want Games host Japan losing money, says Asian Olympic official
-
Trump signs bill authorizing sweeping Russia sanctions
-
Ed Sheeran returns to stage after Palestinian controversy
-
Protesters form human chain at Kennedy Center after Trump threat
-
Asian Games to open in Japan after troubled build-up
-
Death toll from attack at police HQ in Pakistan rises to 31
-
Drone owners rush to offload devices ahead of Beijing ban
-
Trump says Denmark to give US 'permanent control' over Greenland security
-
Trump's beef policies irk Texas ranchers, testing their loyalty
-
Kennedy Center: future unclear for iconic Washington arts hub
-
Nvidia, OpenAI CEOs to attend Xi dinner at White House
-
Trump claims 'infinite' Greenland security deal with Denmark
-
Anthropic picks Accenture for in-house AI safety evaluation
-
Helicopters battle wildfire threatening Ecuador's capital
-
Balogun returns as Monaco beat Lens to continue strong Ligue 1 start
-
Brentford batter Chelsea to undo Alonso's promising start
-
'Pause' on overt repression in Venezuela, but reforms still needed: HRW
-
Kane hits Bundesliga century as Bayern rout Union
-
Global stocks mixed as yen falls despite Bank of Japan rate hike
-
Trump says CNN, MS NOW, Politico banned from White House
-
Cuba hit with seventh major blackout of the year
-
Hushing and hedging: US companies retreat on climate
-
Murray out with concussion so Wentz will start for Vikings
-
Springboks to face Fiji before 2027 Rugby World Cup
-
UN chief 'deeply regrets' US visa refusal to Abbas for annual meeting
-
Nigeria miners struggled to breathe in cell before 37 died: survivors
-
England quick Carse to face no charges over alleged nightclub assault
-
McIlroy on the charge at PGA Championship as Reed withdraws
-
Mancini brings nine newcomers into the first squad of his Italy comeback
-
McIlroy on the charge at PGA Championship
-
Czechs level Davis Cup tie against USA as South Korea eye Finals
-
Crisis-wracked Volkswagen warns of 10-bn-euro hit to profits
-
New France boss Zidane confirms Mbappe as captain after naming first squad
-
Costa Rica's Grynspan tops third informal poll for UN chief: diplomat
-
California governor signs order to explore AI 'kill switch'
-
Stock markets retreat after central bank rate hikes
-
Head leads run spree as Australia win Zimbabwe ODI series
-
Russia labels director of Cannes Grand Prix winner a 'foreign agent'
-
In-form Raphinha wants to finish career at Barcelona
-
Macron warns of Russian 'hybrid' threat after meeting presidential hopefuls
-
Warren Buffett steps down as Berkshire Hathaway chairman
-
UN holds third informal poll for new chief
-
Carrick confident Man Utd can 'work through' tough time
-
Kulusevski return can spark Spurs: De Zerbi
-
Mbappe ends Nike partnership to join Swiss brand On
-
Shakira to cap off world tour with Madrid 12-gig run
-
Liverpool boss Iraola puts Bournemouth love affair on hold
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
T.Resende--PC